Sunshine Biopharma (SBFM) Operating Leases (2019 - 2026)
Sunshine Biopharma (SBFM) posted Operating Leases of $535614.0 for Q1 2026, down 10.25% on a QoQ basis from $596785.0 in Q4 2025, and down 25.84% year-over-year from $722199.0 in Q1 2025.
Sunshine Biopharma (SBFM) Operating Leases (2019 - 2026) Analysis & Trends
Sunshine Biopharma's Operating Leases history runs 6 years deep, the most recent figure standing at $535614.0 for Q1 2026.
- Quarterly Operating Leases fell 25.84% year-over-year to $535614.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $535614.0 (down 25.84% YoY) and the FY2025 annual result came in at $596785.0, down 19.86% from the prior year.
- Operating Leases was $535614.0 for Q1 2026 at Sunshine Biopharma, down from $596785.0 in the prior quarter.
- Across five years, Operating Leases topped out at $744724.0 in Q4 2024 and bottomed at $440298.0 in Q3 2024.
- A 5-year average of $592119.4 and a median of $596817.5 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2025 — Operating Leases jumped 52.63% — and 2026, when it slipped 25.84%.
- Sunshine Biopharma's Operating Leases stood at $642232.0 in 2022, then slipped by 16.07% to $539035.0 in 2023, then soared by 38.16% to $744724.0 in 2024, then declined by 19.86% to $596785.0 in 2025, then slipped by 10.25% to $535614.0 in 2026.
- Business Quant data shows SBFM's Operating Leases at $535614.0 in Q1 2026, $596785.0 in Q4 2025, and $636708.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 535,614.00 |
| Dec 31, 2025 | 596,785.00 |
| Sep 30, 2025 | 636,708.00 |
| Jun 30, 2025 | 706,530.00 |
| Mar 31, 2025 | 722,199.00 |
| Dec 31, 2024 | 744,724.00 |
| Sep 30, 2024 | 440,298.00 |
| Jun 30, 2024 | 462,906.00 |
| Mar 31, 2024 | 496,968.00 |
| Dec 31, 2023 | 539,035.00 |
| Sep 30, 2023 | 555,687.00 |
| Jun 30, 2023 | 596,850.00 |
| Mar 31, 2023 | 613,136.00 |
| Dec 31, 2022 | 642,232.00 |
| Mar 31, 2019 | 49,148.00 |